{
    "title": "Breast cancer drug licensed for women in early stage of disease",
    "url": "https://www.dailymail.co.uk/wires/pa/article-3252829/Breast-cancer-drug-licensed-women-early-stage-disease.html",
    "date": "2015-09-28",
    "keywords": [
        "cancer",
        "breast",
        "drug",
        "perjeta",
        "care",
        "stage",
        "disease",
        "gmt",
        "september",
        "surgery",
        "impact",
        "pertuzumab",
        "use",
        "number",
        "press",
        "association",
        "email",
        "eradication",
        "survival",
        "diseaseperjeta",
        "bodyit",
        "licence",
        "body",
        "institute",
        "health",
        "excellence",
        "nice",
        "nhsit",
        "access",
        "data",
        "manufacturer",
        "medicine",
        "potential",
        "earlystage",
        "cancerdr",
        "oncologist",
        "christie",
        "nhs",
        "foundation",
        "trust",
        "manchester",
        "therapy",
        "casesperjeta",
        "her2",
        "protein",
        "surface",
        "cellsperjeta",
        "cell",
        "combination",
        "treatment",
        "herceptin",
        "trastuzumab",
        "chemotherapysamia",
        "al",
        "qadhi",
        "executive",
        "deathsshe",
        "mastectomy",
        "side",
        "priority",
        "day"
    ],
    "category": [
        "wires",
        "pa"
    ]
}